Literature DB >> 10097685

Korean Nationwide Surveillance of Antimicrobial Resistance of bacteria in 1997.

Y Chong1, K Lee, Y J Park, D S Jeon, M H Lee, M Y Kim, C H Chang, E C Kim, N Y Lee, H S Kim, E S Kang, H C Cho, I K Paik, H S Lee, S J Jang, A J Park, Y J Cha, S H Kang, M H Lee, W Song, J H Shin.   

Abstract

Antimicrobial-resistant bacteria are known to be prevalent in tertiary-care hospitals in Korea. Twenty hospitals participated to this surveillance to determine the nationwide prevalence of resistance bacteria in 1997. Seven per cent and 26% of Escherichia coli and Klebsiella pneumoniae were resistant to 3rd-generation cephalosporin. Increased resistance rates, 19% of Acinetobacter baumannii to ampicillin/sulbactam, and 17% of Pseudomonas aeruginoa to imipenem, were noted. The resistance rate to fluoroquinolone rose to 24% in E. coli, 56% in A. baumannii and 42% in P. aeruginosa. Mean resistance rates were similar in all hospital groups: about 17% of P. aeruginosa to imipenem, 50% of Haemophilus influenzae to ampicillin, 70% of Staphylococcus aureus to methicillin, and 70% of pneumococci to penicillin. In conclusion, nosocomial pathogens and problem resistant organisms are prevalent in smaller hospitals too, indicating nosocomial spread is a significant cause of the increasing prevalence of resistant bacteria in Korea.

Entities:  

Mesh:

Year:  1998        PMID: 10097685     DOI: 10.3349/ymj.1998.39.6.569

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  13 in total

1.  Rifaximin for the treatment of acute infectious diarrhea.

Authors:  Kyoung Sup Hong; Joo Sung Kim
Journal:  Therap Adv Gastroenterol       Date:  2011-07       Impact factor: 4.409

2.  Efficacy of rifaximin compared with ciprofloxacin for the treatment of acute infectious diarrhea: a randomized controlled multicenter study.

Authors:  Kyoung Sup Hong; You Sun Kim; Dong Soo Han; Chang Hwan Choi; Byung-Ik Jang; Young-Sook Park; Kang-Moon Lee; Soo Teik Lee; Hyun-Soo Kim; Joo Sung Kim
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

3.  Vancomycin-intermediate Staphylococcus aureus in Korea.

Authors:  M N Kim; C H Pai; J H Woo; J S Ryu; K Hiramatsu
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

4.  Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.

Authors:  Kyungwon Lee; Mi Ae Lee; Chae Hoon Lee; Jongwook Lee; Kyoung Ho Roh; Sunjoo Kim; Jin Ju Kim; Eunmi Koh; Dongeun Yong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

5.  High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004.

Authors:  Kyungwon Lee; Chang Hyun Lim; Ji Hyun Cho; Wee Gyo Lee; Young Uh; Hwi Jun Kim; Dongeun Yong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

6.  Antimicrobial resistance among commensal isolates of Escherichia coli and Staphylococcus aureus in the Indonesian population inside and outside hospitals.

Authors:  E S Lestari; J A Severin; P M G Filius; K Kuntaman; D O Duerink; U Hadi; H Wahjono; H A Verbrugh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10-13       Impact factor: 3.267

7.  Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.

Authors:  Kyungwon Lee; Mi-Na Kim; Jae-Seok Kim; Hye Lim Hong; Jung Oak Kang; Jong Hee Shin; Yeon-Joon Park; Dongeun Yong; Seok Hoon Jeong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2011-09       Impact factor: 2.759

8.  Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections.

Authors:  Kibum Jeon; Seri Jeong; Nuri Lee; Min-Jeong Park; Wonkeun Song; Han-Sung Kim; Hyun Soo Kim; Jae-Seok Kim
Journal:  Antibiotics (Basel)       Date:  2022-04-18

9.  Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.

Authors:  Kyungwon Lee; Ki Hyung Park; Seok Hoon Jeong; Hwan Sub Lim; Jong Hee Shin; Dongeun Yong; Gyoung-Yim Ha; Yunsop Chong
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

Review 10.  Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review.

Authors:  Setareh Mamishi; Sepideh Moradkhani; Shima Mahmoudi; Reihaneh Hosseinpour-Sadeghi; Babak Pourakbari
Journal:  Iran J Microbiol       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.